Jane Street’s PMV Pharmaceuticals PMVP Stock Holding History

Jane Street’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$154K	Sell	124,014 -374,627	-75%	-$476K	﹤0.01%	10368
2025 Q4	$623K	Buy	498,641 +116,591	+31%	+$156K	﹤0.01%	7198
2025 Q3	$535K	Buy	+382,050	New	+$529K	﹤0.01%	7718
2025 Q1	–	Sell	-49,870	Closed	-$75.3K	–	10353
2024 Q4	$75.3K	Sell	49,870 -24,219	-33%	-$38.4K	﹤0.01%	8863
2024 Q3	$110K	Sell	74,089 -89,957	-55%	-$139K	﹤0.01%	8956
2024 Q2	$266K	Buy	164,046 +136,066	+486%	+$245K	﹤0.01%	7978
2024 Q1	$47.6K	Buy	27,980 +803	+3%	+$1.5K	﹤0.01%	8750
2023 Q4	$84.2K	Sell	27,177 -11,857	-30%	-$31.4K	﹤0.01%	8648
2023 Q3	$240K	Buy	+39,034	New	+$268K	﹤0.01%	7381
2023 Q2	–	Sell	-235,447	Closed	-$1.12M	–	9380
2023 Q1	$1.12M	Buy	235,447 +162,927	+225%	+$1.15M	﹤0.01%	4789
2022 Q4	$631K	Buy	72,520 +48,593	+203%	+$518K	﹤0.01%	5736
2022 Q3	$285K	Sell	23,927 -1,048	-4%	-$15.1K	﹤0.01%	7673
2022 Q2	$356K	Buy	+24,975	New	+$363K	﹤0.01%	7324
2020 Q4	–	Sell	-31,349	Closed	-$1.11M	–	7964
2020 Q3	$1.11M	Buy	+31,349	New	+$1.15M	﹤0.01%	3930

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jane Street's PMVP Position: Q1 2026 in Review

Jane Street reduced its PMV Pharmaceuticals (PMVP) stake by 75% in Q1 2026, selling an estimated $476K and leaving 124,014 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #10368.

Jane Street first reported a position in PMVP in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.12M in Q1 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

Jane Street held 124,014 shares of PMV Pharmaceuticals worth $154K as of Q1 2026.
Jane Street sold 374,627 PMV Pharmaceuticals shares in Q1 2026, an estimated $476K.
PMV Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10368 holding.
Jane Street first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 14 quarters since.
Jane Street's PMV Pharmaceuticals position peaked at $1.12M in Q1 2023.
69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.